Aristo Bio-Tech And Lifescience Limited (NSE: ARISTO), ISIN INE082101010 — earnings, PEAD surprise, concall summary, Walk-the-Talk management consistency, SAST and insider filings, and the EquiSense Score (ECS), all in plain English on EquiSense.
ARISTO last traded at ₹109.25 (-5.00%), with a 52-week range of ₹74.30 to ₹140.00 (as of 22 Jul 2026).
Shareholding as of Mar 2026: promoters 73.42%, FIIs 0.00%, DIIs 0.00%, mutual funds 0.00%.
EquiSense Score (ECS): 77/100.
Data sourced from NSE and BSE filings. Educational — not investment advice.